First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
about
Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsPET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectivesPeptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR).The Cohesive Metastasis Phenotype in Human Prostate Cancer.PET Tracers Beyond FDG in Prostate Cancer.Preclinical evaluation of [111 In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity.Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer.Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.uPAR directed-imaging of head-and-neck cancer.An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
P2860
Q28077999-B0AC2FFE-BE09-4AD2-B2BC-FDB849BC3184Q28078479-D3DFC813-BDF8-4D8F-BD91-38A8F3D99FFCQ35909379-D1C79A8D-E383-42D4-A7E7-45C859B5466CQ36568335-2C0BED5C-26E1-41E6-B251-4F9DE2FF3928Q37687496-CF3C429E-5656-4173-9393-DC538F1732A9Q37716562-30015DBF-B93C-4E0A-B2E2-62CC7617C1E4Q38711633-BF1A575D-3415-4BC8-92D9-3AFD6B7EA199Q38966462-0B156AAA-DE2E-42F9-999A-050301AA217FQ39003086-972AB247-06F7-4466-B919-A92A01644246Q39456396-D6902D5F-CEED-4A02-936E-F28267954649Q40258398-BDB5E0EC-B87B-44B9-B470-82AAF4D457ABQ41559739-2925F35F-5910-451E-BE84-399BB2EB6D0AQ42360119-CC7BD03E-598F-47D4-975C-AC75DF401CF5Q47288042-B42A8E39-4088-48EF-AE59-2929FB02540FQ54960825-5BAE95F7-2B1E-46C7-8C59-34AE0197D8BA
P2860
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
@ast
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
@en
type
label
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
@ast
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
@en
prefLabel
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
@ast
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
@en
P2093
P2860
P50
P356
P1433
P1476
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
@en
P2093
Anne Kiil Berthelsen
Annika Loft
Camilla Christensen
Carsten H Nielsen
Dorthe Skovgaard
Jacob Madsen
Klaus Brasso
Malene Brandt-Larsen
Morten Persson
Niels Kroman
P2860
P304
P356
10.7150/THNO.12956
P577
2015-09-13T00:00:00Z